Literature DB >> 2651654

Animal models for Pneumocystis carinii pneumonia.

W T Hughes1.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2651654     DOI: 10.1111/j.1550-7408.1989.tb02688.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


× No keyword cloud information.
  6 in total

1.  Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats.

Authors:  A Sukura; T Soveri; L A Lindberg
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.

Authors:  M Brun-Pascaud; P Rajagopalan-Levasseur; F Chau; G Bertrand; L Garry; F Derouin; P M Girard
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Naturally acquired Pneumocystis carinii pneumonia in gene disruption mutant mice: roles of distinct T-cell populations in infection.

Authors:  R Hanano; K Reifenberg; S H Kaufmann
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Characterization of the PNT1 pentamidine resistance gene of Saccharomyces cerevisiae.

Authors:  G Ludewig; C Staben
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

5.  Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii.

Authors:  J C Comley; R J Mullin; L A Wolfe; M H Hanlon; R Ferone
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Effects of pentamidine isethionate on Saccharomyces cerevisiae.

Authors:  G Ludewig; J M Williams; Y Li; C Staben
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.